Skip to content
  • Diet & Nutrition
  • Lifestyle & Wellbeing
  • News & Research
  • Treatment & Management
  • Patient Narratives
  • Glycaemic Index
  • Carbohydrate Counting
Quest Diabetes
Quest Diabetes
  • Diet & Nutrition
  • Lifestyle & Wellbeing
  • News & Research
  • Treatment & Management
  • Patient Narratives
  • Glycaemic Index
  • Carbohydrate Counting
Quest Diabetes
  • News & Research

Egypt boosts insulin security with first local batch amid push for pharmaceutical self-sufficiency

Egypt’s health authorities highlight a strategic shift towards local insulin production, aiming to reduce reliance on imports and secure medicines for its burgeoning diabetic population, with plans to expand exports across Africa. Egypt’s health minister has said the country’s insulin…

  • apxadmin
  • August 11, 2026
  • Diet & Nutrition

Russian expert challenges stereotype linking obesity only to diabetes risk

A Russian therapist highlights that diabetes can develop in individuals of normal weight, emphasising the roles of genetics and body composition in the disease’s onset. A Russian therapist has pushed back against the widespread belief that diabetes only affects people…

  • apxadmin
  • August 11, 2026
  • Lifestyle & Wellbeing

Russian expert highlights overlooked risk of diabetes in lean and 'skinny fat' individuals

A Russian therapist warns that diabetes can develop in individuals who appear lean or carry atypical fat distribution, challenging the conventional association with excess weight. With millions of Russians unaware they have the condition, experts stress the importance of recognising…

  • apxadmin
  • August 11, 2026
  • Lifestyle & Wellbeing

Silent progression of diabetic kidney disease highlights need for early testing

Diabetic kidney disease often develops silently over years before symptoms appear, underscoring the importance of regular testing and early intervention to prevent irreversible damage. Kidney disease linked to diabetes can develop for years before most people notice anything is wrong,…

  • apxadmin
  • August 11, 2026
  • Lifestyle & Wellbeing

Britain's rising tide of type 2 diabetes among women under 40 challenges assumptions

New research reveals that type 2 diabetes is increasing rapidly among women under 40 in Britain, disrupting the traditional view that it is mainly an illness of older adults and highlighting a widening public health challenge. New research from Britain…

  • apxadmin
  • August 10, 2026
  • Diet & Nutrition

Rise in type 2 diabetes diagnoses among women under 40 signals alarming generational shift

Research indicates a surge in type 2 diabetes diagnoses among women under 40, highlighting a shift towards younger populations and raising concerns over lifestyle factors and missed diagnoses. Type 2 diabetes is increasingly being diagnosed in younger adults, with the…

  • apxadmin
  • August 10, 2026
  • News & Research

Egypt boosts domestic insulin production amid rising diabetes rates

Egypt’s growing diabetes prevalence is driving a push to expand local insulin manufacturing, aiming to reduce reliance on imports while meeting increasing demand in one of the world’s most affected countries. Egypt’s rising diabetes burden is putting sustained pressure on…

  • apxadmin
  • August 10, 2026
  • Diet & Nutrition

Blackcurrant jam with fructose offers a tart, nutritious alternative that balances tradition and restraint

A low-sugar blackcurrant jam made with fructose showcases a delicate balance between rich, tart flavour and health-conscious sweetness, emphasising slow cooking to preserve colour and nutrition. This innovative approach appeals to those seeking both tradition and modern dietary considerations, especially…

  • apxadmin
  • August 10, 2026
  • Treatment & Management

UK becomes first in Europe to approve Eli Lilly's oral GLP-1 weight loss pill foundayo

Eli Lilly’s new once-daily weight management tablet, foundayo, gains UK approval, marking a significant step in the evolving market for oral GLP-1 therapies amid increasing investor interest and market competition. Eli Lilly has won British approval for Foundayo, a once-daily…

  • apxadmin
  • August 10, 2026
  • Patient Narratives

GLP-1 medicines show potential for broader metabolic and cardiovascular benefits beyond weight loss, study find

New research indicates that different formulations of GLP-1 receptor agonists may offer diverse benefits including blood sugar, blood pressure, and cholesterol improvements, paving the way for tailored treatments beyond obesity management. A new analysis suggests GLP-1 medicines may do more…

  • apxadmin
  • August 10, 2026
Prev
1 … 56 57 58 59 60 61 62 … 83
Next

Search

No results

Posts

Personal glucose pattern analyser offers targeted insights for diabetes management

August 6, 2026

Eli Lilly takes legal action over black market sales of experimental diabetes drug retatrutide

August 12, 2026

Eating carbohydrates earlier in the day may improve blood sugar control and energy levels

August 31, 2026

University College Dublin tests scalable digital support for pregnant women at high risk of gestational diabetes

September 1, 2026

Laurence Girard’s healthcare model pivots around physician-backed telehealth diabetes prevention

August 12, 2026

Trending now

Borderline HbA1c levels signal rising cardiovascular risk and need for early intervention
Latest consumer guidance underscores the importance of meal patterns over miracle sleep foods
Understanding the diverse chemistry and health implications of different sugars
New emphasis on variety and portion control in vegetables for managing diabetes

Copyright © 2026 - QuestDiabetes.com

Disclaimer | Terms & Conditions | Privacy Policy